Bill DeGrado

Bill DeGrado

Commercial Services
Consumer Services
Health Technology

Profiel

Bill DeGrado is the founder of Pliant Therapeutics, Inc. (founded in 2015).
He currently holds positions at American Academy of Arts & Sciences, Cardiovascular Research Institute, and UCSF School of Pharmacy as a Member, Member, and Professor respectively.
In the past, he worked at the University of Pennsylvania as a Professor in the Biochemistry & Biophysics Department, DuPont Merck Pharmaceutical Co. as a Member, National Academy of Inventors as a Member, The Protein Society as the President, and DuPont Central Research as a Member.
Dr. DeGrado obtained a doctorate degree from The University of Chicago and an undergraduate degree from Kalamazoo College.

Actieve functies van Bill DeGrado

BedrijvenFunctieBegin
PLIANT THERAPEUTICS, INC. Oprichter 01-06-2015
Corporate Officer/Principal -
Corporate Officer/Principal -
UCSF School of Pharmacy Corporate Officer/Principal -
Alle actieve functies van Bill DeGrado

Eerdere bekende functies van Bill DeGrado

BedrijvenFunctieEinde
President -
Corporate Officer/Principal -
Corporate Officer/Principal -
University of Pennsylvania Corporate Officer/Principal -
DuPont Central Research Corporate Officer/Principal -
Ervaring van Bill DeGrado in detail bekijken

Opleiding van Bill DeGrado

Kalamazoo College Undergraduate Degree
The University of Chicago Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Bill DeGrado in detail bekijken

Connecties

100 +

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven1
PLIANT THERAPEUTICS, INC.

Health Technology

Bedrijven in privébezit6

Commercial Services

DuPont Central Research

Health Technology

Commercial Services

Commercial Services

Commercial Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Bill DeGrado
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU